In October, new dialogue platforms on breast cancer will emerge through social media

The social media will, this year more than in any other, deck themselves out in pink, in October – opening up the door to dialogue between professionals and Internet users, on the subject of breast cancer. 

From October 3-28, the French Association for Cancer Research (ARC) will open an online platform, so that the general public can engage in discussion with four renowned researchers, on a variety of topics related to breast cancer. The new platform will be launched as part of Pink October, the month dedicated to official mobilisation against breast cancer, so as to raise awareness and inform Internet users on the subject. 

Benchmarking Pharmaceutical Companies Online Communication Practices

When one thousand Web sites produced by some of the world’s foremost pharmaceutical companies - AstraZeneca, Eli Lilly, GlaxosmithKline, Janssen, Merck/MSD, Novartis, Pfizer, Roche and Sanofi-Aventis – were catalogued and analysed across five geographic zones, one of the key facts that emerged was the predominance of the diabetes as the focus of satellite sites, over other major therapeutic areas.

The multi-criteria grids developed by LexisNexis Analytics make it possible to also identify, within each therapeutic area, the most innovative and differentiating online tools used by the laboratories in order to communicate with their various audiences (patients, healthcare professionals, etc.), which they base on traditional Web, mobile Web or social media.